Novel Object Recognition

Overview

The novel object recognition (NOR) test evaluates episodic-like recognition memory in rodents by exploiting their innate preference for novelty. During the sample phase, the subject explores two identical objects in an open arena; after a defined retention interval, one object is replaced with a novel object. Performance depends on perirhinal cortex integrity for object identity processing and hippocampal circuits when spatial or contextual demands are introduced. The test is widely used to model declarative memory impairments relevant to Alzheimer's disease and age-related cognitive decline.

The primary outcome measure is the discrimination index (DI), calculated as (time at novel object minus time at familiar object) divided by total exploration time, yielding values from negative one to positive one. A positive DI indicates intact recognition memory, while values near zero suggest chance-level performance. Total exploration time serves as a critical control variable to exclude trials with insufficient sampling. Additional measures include contact frequency, latency to first contact with the novel object, and distance traveled as an index of general locomotor activity.

ConductMaze automates NOR scoring by defining object interaction zones and applying nose-point tracking with a configurable proximity threshold. The system timestamps every entry, exit, and contact event, eliminating manual stopwatch scoring and inter-rater variability. Discrimination indices, exploration ratios, and bout analyses are computed in real time and exported alongside raw tracking coordinates. Automated arena calibration ensures consistent zone geometry across sessions and cohorts.

Trial Flow

start

Habituation

Place subject in empty arena for habituation period to reduce neophobia.

input

Sample Phase

Introduce two identical objects (A1, A2); subject explores freely for sample duration.

process

Retention Interval

Return subject to home cage for the defined inter-trial interval.

input

Test Phase

Replace one object with novel object (B); subject explores A1 and B freely.

decision

Discrimination Scoring

Compute discrimination index from exploration times; flag trials below minimum exploration threshold.

output

Data Export

Export DI, exploration times, bout counts, and trajectory heatmaps per subject.

end

Trial Complete

Clean arena and objects with 70% ethanol; prepare for next subject.

Parameters

ParameterTypeDefaultDescription
Habituation Durationduration10 minTime subject explores the empty arena before sample phase.
Sample Phase Durationduration10 minMaximum time for exploration of identical object pair.
Retention Intervalduration1 hrDelay between sample and test phases in home cage.
Test Phase Durationduration5 minMaximum time for exploration during the choice test.
Object Interaction Zone Radiusdistance2 cmProximity threshold from object boundary for scoring an interaction.
Minimum Exploration Criterionseconds20Minimum total exploration time during test phase for trial inclusion.
Arena Diameterdistance40 cmDiameter of the circular open field arena.
Object Placement Distancedistance10 cmDistance from arena wall center to object center.

Metrics

MetricUnitDescription
Discrimination IndexratioRatio of differential exploration to total exploration, ranging from -1 to +1.
Novel Object Exploration TimesTotal seconds spent exploring the novel object during the test phase.
Familiar Object Exploration TimesTotal seconds spent exploring the familiar object during the test phase.
Total Exploration TimesSum of novel and familiar object exploration during the test phase.
Latency to Novel ObjectsTime from test phase start to first contact with the novel object.
Exploration Bout CountcountNumber of discrete exploration bouts across both objects.
Distance TraveledcmTotal locomotor path length during the test phase.

Sample Data

SubjectGroupNovel Time (s)Familiar Time (s)Discrimination IndexDistance (cm)

Representative data for illustration purposes. Actual values will vary by species, strain, and experimental conditions.

Applications

  • 1
    Alzheimer's Disease ModelingAssess recognition memory deficits in transgenic APP/PS1 or 5xFAD mice as a translational endpoint for amyloid-targeting therapeutics.
  • 2
    Cholinergic Drug ScreeningEvaluate procognitive effects of acetylcholinesterase inhibitors or muscarinic agonists on perirhinal-dependent object memory.
  • 3
    Aging and NeurodegenerationCompare NOR performance across age cohorts to characterize the onset and progression of age-related memory decline.
  • 4
    Traumatic Brain InjuryQuantify recognition memory impairment following controlled cortical impact or fluid percussion injury models.

Compatible Products

ME-NORCS-958344

Ready to Automate Your Behavioral Protocols?

Contact us for a demo and pricing information.